Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine

mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

(2022) Wilfredo F. Garcia-Beltran et al.   CELL

Will the COVID-19 pandemic end with the Delta and Omicron variants?

(2022) Chaoqi Wang et al.   Environmental Chemistry Letters

Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose

(2022) Constanze Kuhlmann et al.   LANCET

Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant

(2022) Yu Gao et al.   NATURE MEDICINE

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination

(2022) Rolando Pajon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine

(2022) Sitthichai Kanokudom et al.   Vaccines

Neutralizing Activities Against the Omicron Variant After a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination

(2022) Suvichada Assawakosri et al.   JOURNAL OF INFECTIOUS DISEASES

Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic

(2021) Abanoub Riad et al.   Journal of Clinical Medicine

COVID-19 vaccination followed by activation of glomerular diseases: does association equal causation?

(2021) Nicholas L. Li et al.   KIDNEY INTERNATIONAL

Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis

(2021) Angela Choi et al.   NATURE MEDICINE

Side Effects of mRNA-Based COVID-19 Vaccine: Nationwide Phase IV Study among Healthcare Workers in Slovakia

(2021) Abanoub Riad et al.   Pharmaceuticals

Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population

(2021) Porntip Intapiboon et al.   Vaccines

Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era

(2021) Stephen Y Wang et al.   Lancet Microbe

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

(2020) Lisa A. Jackson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Allocation criteria for an initial shortage of a future SARS-CoV-2 vaccine and necessary measures for global immunity

(2020) Wolfram Henn   VACCINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE